BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15728142)

  • 1. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae.
    Bozdogan B; Tristram S; Appelbaum PC
    J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
    Derbyshire H; Kay G; Evans K; Vaughan C; Kavuri U; Winstanley T
    J Antimicrob Chemother; 2009 Mar; 63(3):497-501. PubMed ID: 19155228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cloned inhibitor-resistant TEM beta-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate.
    Tristram SG; Burdach JG
    J Antimicrob Chemother; 2007 Nov; 60(5):1151-4. PubMed ID: 17827143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.
    De Gheldre Y; Avesani V; Berhin C; Delmée M; Glupczynski Y
    J Antimicrob Chemother; 2003 Oct; 52(4):591-7. PubMed ID: 12972449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae.
    Hope R; Potz NA; Warner M; Fagan EJ; Arnold E; Livermore DM
    J Antimicrob Chemother; 2007 Jan; 59(1):110-3. PubMed ID: 17090552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V; Bozdogan B; Jacobs MR; Ubukata K; Appelbaum PC
    J Antimicrob Chemother; 2003 Dec; 52(6):1018-21. PubMed ID: 14585854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs.
    Kärpänoja P; Nissinen A; Huovinen P; Sarkkinen H
    J Antimicrob Chemother; 2004 Apr; 53(4):660-3. PubMed ID: 14973151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of N526K-substituted penicillin-binding protein 3 conferring low-level mutational resistance to β-lactam antibiotics in Haemophilus influenzae by disc diffusion testing on Mueller-Hinton agar according to EUCAST guidelines.
    Søndergaard A; Petersen MT; Fuursted K; Nørskov-Lauritsen N
    J Antimicrob Chemother; 2012 Jun; 67(6):1401-4. PubMed ID: 22389455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
    Sader HS; Jacobs MR; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alarmingly decreasing rates of amoxicillin-clavulanate susceptibility among clinical isolates of Haemophilus influenzae from 2001 to 2009 in a medical center in Taiwan.
    Chung KP; Huang YT; Lee LN; Yu CJ; Lai CC; Hsueh PR
    J Infect; 2011 Feb; 62(2):185-7. PubMed ID: 21145354
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.